Australian Clinical Labs Limited logo

Australian Clinical Labs Limited (ACL)

Market Open
CXA CXA
- Market Cap
29.58 P/E Ratio
- Div Yield
25,204 Volume
0.16 Eps
Want to track ACL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ACL is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

Australian Clinical Labs Limited (ACL) FAQ

On which exchange is it traded?

Australian Clinical Labs Limited is listed on CXA.

What is its stock symbol?

The ticker symbol is ACL.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Australian Clinical Labs Limited ever had a stock split?

No, there has never been a stock split.

Australian Clinical Labs Limited Profile

Professional Services Industry
Industrials Sector
Ms. Melinda McGrath CEO
CXA Exchange
- ISIN
Australia Country
4,900 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Established in 2020 and headquartered in Clayton, Australia, Australian Clinical Labs Limited specializes in providing a wide spectrum of pathology services throughout the country. The company is known for catering to both private and public health sectors, ensuring quality diagnostics and testing services which are fundamental to effective healthcare delivery. By integrating advanced testing methodologies and comprehensive service offerings, Australian Clinical Labs Limited aims to support healthcare professionals in delivering precise and timely patient care.

Products and Services

  • Routine pathology test: Essential diagnostic services covering a broad range of common medical tests for health assessment and monitoring.
  • Advanced molecular genetics testing: Cutting-edge genetic analysis to identify genetic disorders, enabling personalized medicine approaches and targeted treatments.
  • Harmony NIPT and first trimester screening: Non-invasive prenatal tests and screening solutions to assess the risk of chromosomal abnormalities in fetuses.
  • Genetic carrier screening: Analysis to identify individuals or couples who are carriers of genetic conditions that could be passed on to their children.
  • Chemical pathology: Examination of the chemical components in blood (such as electrolytes, proteins, and enzymes) to diagnose and manage diseases.
  • Histopathology and cytopathology: The study of tissue and cells, respectively, to diagnose diseases, including cancer, by examining samples under a microscope.
  • Hematology: Focuses on diseases related to the blood and blood-forming organs, including anemia, leukemia, lymphoma, and clotting disorders.
  • Allergy and immunology: Testing for allergic reactions and immune system disorders, helping in the diagnosis and management of allergies and autoimmune diseases.
  • Serology and microbiology: Identification of antibodies and antigens in the blood to diagnose infections; microbiology involves studying microorganisms to diagnose infectious diseases.
  • Infectious molecular testing: Uses molecular techniques to detect and quantify pathogens, providing rapid and accurate diagnosis of infectious diseases.
  • Cardiac testing services: A range of tests to assess heart function and diagnose cardiovascular conditions, including ECG and heart marker analysis.
  • Functional pathology: Evaluates how organs and systems are functioning, rather than looking for specific diseases, to assist in comprehensive health assessments.
  • Veterinary pathology: Diagnostic services for animals, covering a wide range of tests from routine lab work to specialized diagnostics.
  • Commercial drug and alcohol testing services: Offers testing solutions for workplaces to ensure compliance with safety standards and regulations regarding substance use.

Contact Information

Address: 1868-1892 Dandenong Road
Phone: 61 1 3004 53688